Topic: MS

Trend to earlier, more aggressive therapy: U.S. survey

September 11, 2014  

Atacicept: the aftermath

September 3, 2014  

New dosing for glatiramer acetate

August 6, 2014  

MS patient website tops 70,000 visits

June 3, 2014  

The time course of MS – AudioSlide presentation

May 28, 2014  

Alemtuzumab receives Health Canada approval

April 23, 2014  

MS treatment failure: who is at risk?

March 19, 2014  

Epstein-Barr and MS: meta-analysis

March 5, 2014  

Brief cognitive screening tool in development

October 5, 2013  

HSCT in aggressive MS: Canadian MS/BMT Study Group results

October 5, 2013